← Leaderboards
Jennifer J Kang-Mieler
Illinois Institute Of Technology
$6,502,963
Attributed
$7,092,352
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,092,352 · 6
By mechanism
R01$6,203,583 · 3
R15$780,769 · 2
R25$108,000 · 1
Top collaborators
- Derek Kamper4 shared
- Yu Gan2 shared
- John V. White1 shared
Most similar at Illinois Institute Of Technology
Same institution · by research overlap
- John V. White$7,200
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyBlood VesselsDiabetic RetinopathyRetinaRodent ModelScanningBaseImaging ModalityOptical Coherence TomographyHemorrhageVascular PermeabilitiesMicrospheresClinical PracticeSiteVascular Endothelial Growth FactorsFluorescein AngiographyHealthcare SystemsBlood FlowMeasurementImageSuccessSafetyAge Related Macular DegenerationAnimals
Grant awards (21)
Deep Learning-based Diagnosis of Retinopathy of Prematurity$504,847
R01 · FY2025 · EY · contact PI
Dynamic Tracer Kinetic Model to Detect Preclinical Diabetic Retinopathy (DR)$441,907
R01 · FY2025 · EY · contact PI
Deep Learning-based Diagnosis of Retinopathy of Prematurity$580,331
R01 · FY2024 · EY · contact PI
Dynamic Tracer Kinetic Model to Detect Preclinical Diabetic Retinopathy (DR)$446,347
R01 · FY2024 · EY · contact PI
Dynamic Tracer Kinetic Model to Detect Preclinical Diabetic Retinopathy (DR)$452,262
R01 · FY2023 · EY · contact PI
Sustained Ocular Drug Delivery System for Anti-VEGF Agents$257,400
R01 · FY2023 · EY · contact PI
Sustained Ocular Drug Delivery System for Anti-VEGF Agents$561,278
R01 · FY2022 · EY · contact PI
Dynamic Tracer Kinetic Model to Detect Preclinical Diabetic Retinopathy (DR)$504,051
R01 · FY2022 · EY · contact PI
Sustained Ocular Drug Delivery System for Anti-VEGF Agents$24,999
R01 · FY2022 · EY · contact PI
Sustained Ocular Drug Delivery System for Anti-VEGF Agents$584,346
R01 · FY2021 · EY · contact PI
Dynamic Tracer Kinetic Model to Detect Preclinical Diabetic Retinopathy (DR)$530,753
R01 · FY2021 · EY · contact PI
Sustained Ocular Drug Delivery System for Anti-VEGF Agents$52,250
R01 · FY2021 · EY · contact PI
Sustained Ocular Drug Delivery System for Anti-VEGF Agents$624,845
R01 · FY2020 · EY · contact PI
Sustained Ocular Drug Delivery System for Anti-VEGF Agents$637,967
R01 · FY2019 · EY · contact PI
Efficacy of the Microsphere-Thermo-Responsive Hydrogel Ocular Drug Delivery System$419,899
R15 · FY2016 · EY · contact PI
BME design challenge of improving surgical safety$21,600
R25 · FY2016 · EB · contact PI
BME design challenge of improving surgical safety$21,600
R25 · FY2015 · EB · contact PI
BME design challenge of improving surgical safety$21,600
R25 · FY2014 · EB · contact PI
BME design challenge of improving surgical safety$21,600
R25 · FY2013 · EB · contact PI
BME design challenge of improving surgical safety$21,600
R25 · FY2012 · EB · contact PI
Biocompatibility of thermo-responsive hydrogel ocular drug delivery system$360,870
R15 · FY2010 · EY · contact PI